Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial-Reference-Cited by-同舟云学术

Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial

Published:2022-05-12 Issue:6 Volume:28 Page:1269-1276
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Haidar Ahmad,Lovblom Leif Erik,Cardinez Nancy,Gouchie-Provencher Nikita,Orszag Andrej,Tsoukas Michael A.,Falappa C. Marcelo,Jafar Adnan,Ghanbari Milad,Eldelekli Devrim,Rutkowski Joanna,Yale Jean-François^ORCID,Perkins Bruce A.^ORCID

Funder

JDRF

Gouvernement du Canada | Canadian Institutes of Health Research

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-01805-3.pdf

Reference37 articles.

1. Haidar, A. The artificial pancreas: how closed-loop control is revolutionizing diabetes. IEEE Control Syst. 36, 28–47 (2016).

2. Brown, S. A. et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N. Engl. J. Med. 381, 1707–1717 (2019).

3. Thabit, H. et al. Use of an artificial beta cell in type 1 diabetes. N. Engl. J. Med. 373, 2129–2140 (2015).

4. Collyns, O. J. et al. Improved glycemic outcomes with Medtronic MiniMed Advanced Hybrid Closed-Loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care 44, 969–975 (2021).

5. Benhamou, P.-Y. et al. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. Lancet Digit. Health 1, e17–e25 (2019).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying technologies to simplify strategies for exercise in type 1 diabetes;Diabetologia;2024-08-15

2. Elevated urinary albumin predicts increased time in range after initiation of SGLT2 inhibitors in individuals with type 1 diabetes on sensor-augmented pump therapy;Diabetology International;2024-08-06

3. Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes;Diabetologia;2024-07-05

4. Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada;The Lancet Digital Health;2024-07

5. Effect of sodium-glucose cotransporter-2 inhibitors on continuous glucose monitoring metrics, as adjunctive to insulin in adults with type 1 diabetes mellitus: a meta-analysis of randomized controlled trials;Metabolism;2024-04